Messages about Black-Box Warnings (original) (raw)

Analysis of US Food and Drug Administration Warning Letters

Pharmaceutical Medicine, 2008

Changes in Side Effect Risk Communication in Patient Information Leaflets over the Past Decade: Results of a Survey

Drug safety, 2015

Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands

Peter Mol

Drug Safety

View PDFchevron_right

Impact of FDA Drug Risk Communications on Health Care Utilization and Health Behaviors

Stacie Dusetzina, Ashley Higashi

Medical Care, 2012

View PDFchevron_right

When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines

P. Mol, Jaap Wieringa

Clinical pharmacology and therapeutics, 2013

View PDFchevron_right

Consumers Prefer Drug Side Effect Information to be Rich in Detail and Easily Accessible

Salman Mirza

View PDFchevron_right

Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab

Barbara Mintzes

British Journal of Clinical Pharmacology, 2020

View PDFchevron_right

Positively Framed Risk Information in Patient Information Leaflets Reduces Side Effect Reporting: A Double-Blind Randomized Controlled Trial

Rebecca K. Webster

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2018

View PDFchevron_right

What can we learn from the public's understanding of drug information and safety? A population survey

Bendaoud Saad

International Journal of Pharmacy Practice, 2018

View PDFchevron_right

The Future of Risk Communication and the Role of the Pharmaceutical Industry

Sweta Chakraborty

View PDFchevron_right

Coverage by the News Media of the Benefits and Risks of Medications

Dennis Ross-Degnan

New England Journal of Medicine, 2000

View PDFchevron_right

Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines and Content for Safe Prescribing

Salomeh Keyhani

PLoS ONE, 2011

View PDFchevron_right

The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance

Brian Edwards

Drug Safety, 2015

View PDFchevron_right

Framing the risk of an OTC medication side effect

Dale Quest

Canadian Pharmacists Journal, 2011

View PDFchevron_right

Black Box Warnings and Drug Safety: Examining the Determinants and Timing of FDA Warning Labels

Randall Lutter

2006

View PDFchevron_right

Improving Prescription Drug Warnings to Promote Patient Comprehension

ruth parker

Archives of Internal Medicine, 2010

View PDFchevron_right

Warnings for drug–drug interactions in consumer medication information provided by community pharmacies

Farshad Shirazi

Journal of the American Pharmacists Association, 2018

View PDFchevron_right

Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements

shivani gandhi

Therapeutic Innovation & Regulatory Science, 2018

View PDFchevron_right

Medication safety messages for patients via the web portal: The MedCheck intervention

Daniel Sands, Anjala Tess

International Journal of Medical Informatics, 2008

View PDFchevron_right

Short- and Long-Term Effects of Auxiliary Labels on Patient Knowledge of Precautionary Drug Information

Brock Guernsey

Drug Intelligence & Clinical Pharmacy, 1988

View PDFchevron_right

Expressing medicine side effects: Assessing the effectiveness of absolute risk, relative risk, and number needed to harm, and the provision of baseline risk information

Peter Knapp

Patient Education and Counseling, 2006

View PDFchevron_right

Exploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leaflets

Susan Blalock

Health Expectations, 2014

View PDFchevron_right

Examining the conspicuousness and prominence of two required warnings on OTC pain relievers

Rafael Auras

Proceedings of the …, 2009

View PDFchevron_right

Adherence to Black Box Warnings for Prescription Medications in Outpatients

Karen Lasser

Archives of Internal Medicine, 2006

View PDFchevron_right

Public engagement and the role of the media in post-marketing drug safety

Jonathan Gabe

Routledge eBooks, 2020

View PDFchevron_right

What is in a Name: Drug Names Convey Implicit Information about Their Riskiness and Efficacy

Alessandra Tasso, Lorella Lotto

Applied Cognitive Psychology, 2014

View PDFchevron_right

Patient-centered approach for improving prescription drug warning labels

ruth parker

Patient Education and Counseling, 2008

View PDFchevron_right

Messages about Black-Box Warnings (original) (raw)

Related papers